Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/14/1342   
Active ingredient: Glucagon
Indication: Treatment of congenital hyperinsulinism
Sponsor: S-cubed Pharmaceutical Services ApS
David Balfours Gade 4, St., Tv, Copenhagen K, Hovedstaden, 1402, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/128/14 (2014)7641 of 15/10/2014
1/09/2017 Change of name and/or address of sponsor
23/01/2019 Transfer of orphan designation EMA/OD/0000003128 (2019)578 of 18/01/2019